Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,749-8,760 of 23,847
Drug study icon
CompletedNCT05279313

A study of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.

This study is looking at whether Centanafadine Hydrochloride can help people with Attention Deficit/Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Dothan
ADHDDrugFrom 4 Years to 18 Years
Countries
United States, Canada
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Behavioral study icon
WithdrawnNCT02476331

A study of Cognitive Training in Euthymic Bipolarity

This study exists to compare options and see whether the medication Cognitive offers something meaningfully different. Researchers are trying to understand whether the medication Cognitive can improve attention, thinking, or day-to-day functioning.

In Calgary
BipolarityBehavioralFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Calgary
Condition
Bipolarity
Behavioral study icon
CompletedNCT02478827

A study of Cognitive Training in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Calgary
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Calgary
Condition
Schizophrenia
Other study type icon
CompletedNCT02357173

A study of E-cigarettes in Current Cigarette Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
AddictionOtherOver 18 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Drug study icon
CompletedNCT05800860

A study of GH001 in people with Treatment-resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Pilsen
DepressionDrugFrom 18 Years to 64 Years
Countries
Czechia, Germany, Ireland, ...
Sponsor
GH Research Ireland Limited
Condition
Depression
Drug study icon
CompletedNCT05273567

A study of Guanfacine-er for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In New York
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.